Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Avalanche Biotechnologies Company Profile (NASDAQ:AAVL)

Consensus Ratings for Avalanche Biotechnologies (NASDAQ:AAVL) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $44.00 (34.80% upside)

Analysts' Ratings History for Avalanche Biotechnologies (NASDAQ:AAVL)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/25/2014William BlairInitiated CoverageOutperform$52.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014Cowen and CompanyInitiated CoverageOutperform$45.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014Piper JaffrayInitiated CoverageOverweight$39.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014Jefferies GroupInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/23/2012 forward)
Discuss Avalanche Biotechnologies